Evidence map›Paper›PMID 38742071›Full record

ArticleHeliyon2024

Automated medication verification system (AMVS): System based on edge detection and CNN classification drug on embedded systems.

Yen-Jung Chiu

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Lessons learned from the safety investigation of an omitted dose-dispensed medicine.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yen-Jung ChiuDepartment of Biomedical Engineering, Ming Chuan University, Taoyuan, 333, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel automated medication verification system (AMVS) aims to address the limitation of manual medication verification among healthcare professionals with a high workload, thereby reducing medication errors in hospitals. Specifically, the manual medication verification process is time-consuming and prone to errors, especially in healthcare settings with high workloads. The proposed system strategy is to streamline and automate this process, enhancing efficiency and reducing medication errors. The system employs deep learning models to swiftly and accurately classify multiple medications within a single image without requiring manual labeling during model construction. It comprises edge detection and classification to verify medication types. Unlike previous studies conducted in open spaces, our study takes place in a closed space to minimize the impact of optical changes on image capture. During the experimental process, the system individually identifies each drug within the image by edge detection method and utilizes a classification model to determine each drug type. Our research has successfully developed a fully automated drug recognition system, achieving an accuracy of over 95 % in identifying drug types and conducting segmentation analyses. Specifically, the system demonstrates an accuracy rate of approximately 96 % for drug sets containing fewer than ten types and 93 % for those with ten types. This verification system builds an image classification model quickly. It holds promising potential in assisting nursing staff during AMVS, thereby reducing the likelihood of medication errors and alleviating the burden on nursing staff.

Indexed as

Deep learningDrugEdge detectionEmbeddingImage classification

Identifiers

PMID38742071
PMCPMC11089321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.